Group B Streptococcus (GBS) screening is a prenatal test performed to identify pregnant women who carry the GBS bacteria, which can cause serious infections in newborns. Screening typically occurs between 35 and 37 weeks of pregnancy, allowing for antibiotic treatment during labor to prevent transmission to the baby.